VASFREE P Tablet 10’s

Description

VASFREE P Tablet is a centrally acting, non-opioid analgesic medication that has been used for the management of moderate to severe pain. unlike traditional painkillers such as nonsteroidal anti-inflammatory drugs (nsaids) or opioids, VASFREE P Tablet works through a unique mechanism that targets neuronal potassium channels and indirectly modulates pain perception. it is often categorized as a selective neuronal potassium channel opener (snepco) and also exhibits n-methyl-d-aspartate (nmda) receptor antagonist properties, which contribute to its analgesic and muscle-relaxant effects.

one of the distinguishing features of VASFREE P Tablet is that it provides pain relief without causing significant sedation or respiratory depression, which are common concerns with opioid analgesics. additionally, it does not have the same gastrointestinal risks associated with nsaids, such as gastric ulcers or bleeding. because of these advantages, VASFREE P Tablet has been considered an alternative option for patients who cannot tolerate conventional pain medications. however, its use has become restricted or discontinued in several countries due to concerns about potential liver toxicity.

VASFREE P Tablet is typically prescribed for conditions involving acute or chronic pain, including musculoskeletal pain, postoperative pain, tension headaches, and pain associated with degenerative disorders. it also has mild muscle-relaxant properties, making it beneficial in conditions where muscle spasm contributes to discomfort. despite its therapeutic benefits, careful monitoring is required, especially for liver function, as prolonged use or high doses may increase the risk of hepatotoxicity.

this medication is intended for adult patients and is generally used when other safer analgesic options are ineffective or contraindicated. due to its safety concerns, healthcare providers carefully evaluate the risks and benefits before prescribing VASFREE P Tablet, and patients are advised to strictly follow medical guidance during treatment.

ingredients

• VASFREE P Tablet maleate: this is the active pharmaceutical ingredient responsible for the analgesic effect. it works by opening neuronal potassium channels, which stabilizes the resting membrane potential of nerve cells and reduces their excitability. this action helps in dampening pain signals transmitted to the brain. additionally, VASFREE P Tablet indirectly inhibits nmda receptors, reducing central sensitization and preventing the amplification of pain signals.
• excipients (inactive ingredients): these may include lactose, magnesium stearate, microcrystalline cellulose, and other formulation-specific agents. they help in stabilizing the drug, improving its absorption, and ensuring proper tablet or capsule formation without contributing to therapeutic effects.

key uses

• management of moderate to severe acute pain, especially when other analgesics are not suitable or effective.
• relief of chronic pain conditions such as musculoskeletal disorders and back pain.
• treatment of pain associated with muscle spasms due to its mild muscle-relaxant properties.
• postoperative pain relief in carefully selected patients under medical supervision.
• management of tension-type headaches where muscle tightness contributes to discomfort.
• adjunct therapy in certain neuropathic pain conditions, although not considered first-line treatment.

how to use

VASFREE P Tablet should be used exactly as prescribed by a qualified healthcare professional. it is usually taken orally in the form of tablets or capsules, with or without food. taking the medication with food may help reduce potential stomach discomfort. the dosage and duration of therapy depend on the severity of the condition, patient response, and overall health status.

patients are advised to swallow the tablet whole with a sufficient amount of water and avoid crushing or chewing it unless specifically instructed. it is important to take the medication at evenly spaced intervals to maintain consistent levels in the bloodstream. since VASFREE P Tablet carries a risk of liver toxicity, it is generally recommended for short-term use, and regular monitoring of liver function tests may be required during treatment.

patients should not exceed the prescribed dose or duration of use, as this significantly increases the risk of adverse effects, particularly liver damage. if pain persists or worsens despite treatment, medical advice should be sought rather than self-adjusting the dose.

safety information

• warnings: VASFREE P Tablet has been associated with serious liver injury, especially when used for prolonged periods or at high doses. it is typically restricted to short-term use, and liver function tests should be monitored during therapy. patients should immediately report symptoms such as yellowing of the skin or eyes (jaundice), dark urine, fatigue, or abdominal pain.
• side effects: common side effects include dizziness, fatigue, nausea, dry mouth, and mild gastrointestinal discomfort. some patients may experience headache or drowsiness. serious side effects include liver dysfunction, allergic reactions, and changes in liver enzyme levels. rarely, severe hepatotoxicity may occur.
• precautions: VASFREE P Tablet should not be used in patients with pre-existing liver disease, alcohol abuse, or those taking other hepatotoxic medications. caution is required in elderly patients and individuals with kidney impairment. regular monitoring is essential during use.
• pregnancy/breastfeeding: the safety of VASFREE P Tablet during pregnancy and breastfeeding has not been well established. it should only be used if clearly necessary and prescribed by a healthcare professional after evaluating potential risks and benefits.
• interactions: VASFREE P Tablet may interact with other medications that affect liver function, including certain antibiotics, antifungals, and anticonvulsants. concurrent use with alcohol significantly increases the risk of liver damage and should be avoided. it may also enhance the sedative effects of central nervous system depressants.

additional information

• storage: store VASFREE P Tablet in a cool, dry place away from direct sunlight and moisture. keep it at room temperature and out of reach of children and pets.
• missed dose: if a dose is missed, it should be taken as soon as remembered. however, if it is close to the next scheduled dose, the missed dose should be skipped. do not double the dose to make up for a missed one.
• overdose: overdose of VASFREE P Tablet may lead to symptoms such as severe drowsiness, confusion, nausea, and liver toxicity. in case of suspected overdose, immediate medical attention is required. supportive care and monitoring are essential.
• habit forming: VASFREE P Tablet is not considered habit-forming or addictive. however, it should still be used responsibly and only under medical supervision to avoid potential complications.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.